Gestational hypertension rates surge in the United States
Gestational hypertension, a condition related to high blood pressure during pregnancy, has seen a remarkable increase in prevalence across the United States, with a report highlighting a 73% rise from 2016 to 2024. In 2024, over 1 in 10 women giving birth were affected, according to data published on July 29 by the US National Center for Health Statistics, reports BritPanorama.
The analysis of birth certificate data revealed that the rate of gestational hypertension grew from 6% in 2016 to 10.4% in 2024; this translated to a rise in absolute numbers from approximately 236,000 cases annually to over 377,000. This increase was consistent across all age groups, as well as racial and ethnic demographics. While every state and the District of Columbia reported higher rates, the prevalence varied significantly by location — from 6.9% in New Jersey to 14.6% in Louisiana.
Importantly, the findings indicate that gestational hypertension may be underreported due to broader definitions used in clinical settings compared to those recorded on birth certificates. Chronic hypertension is defined as high blood pressure that predates pregnancy or occurs in the first 20 weeks, while preeclampsia develops after 20 weeks with accompanying organ dysfunction.
Health expert Dr. Leana Wen indicates this growing trend could be attributed to several interrelated factors. The age of prospective mothers is increasing, alongside rising obesity rates and the frequency of multiple births. These factors alone, however, may not fully account for the substantial rise, which could also stem from changing diagnostic criteria and improved awareness among healthcare providers. Continued research is necessary to discern whether the trend reflects actual deteriorations in pregnant women’s health or shifts in diagnostic practices.
Hypertensive disorders during pregnancy carry risks for both mothers and infants. For infants, potential complications can include low birth weight, preterm deliveries, and stillbirth, alongside the potential for serious conditions such as placental abruption. Mothers face significant health risks, including organ damage and increased susceptibility to stroke. Notably, gestational hypertension can further develop into preeclampsia, which may lead to life-threatening conditions like eclampsia.
The study particularly highlights the demographics most affected by this condition. Women aged 40 and over exhibit the highest incidence, while obesity prior to pregnancy emerges as a significant risk factor, with the prevalence among obese women being more than double that of those with normal weight. Moreover, American Indian and Alaska Native women report the highest rates, suggesting disparities in healthcare access might contribute to these differences.
Dr. Wen advises that women intending to conceive should optimize their health conditions before pregnancy by managing pre-existing conditions and maintaining a healthy weight. Certain symptoms, including severe headaches and vision changes, warrant immediate medical evaluation as they could signify developing preeclampsia. Ultimately, increased awareness and proactive management of blood pressure may mitigate risks associated with gestational hypertension, which remains a critical area for ongoing public health focus.
The findings suggest that addressing gestational hypertension is essential not only for safeguarding maternal and fetal health but also for understanding broader trends in public health and healthcare access across diverse populations.
